Leaders and Key Contacts.
Arriello’s founders & directors.
Alan's role is to lead the organization with the drive and energy required to continue to make the company a success. He has a close connection to the Commercial activities of the company, working closely with the CCO and Head of Marketing.
Alan has worked in the Pharmaceutical space since 2005 but also has commercial experience in the IT, architectural and lighting sectors.
It is this broad range of experiences that gives Alan a different perspective on the industry he works in.
Common to all these areas is his ability to problem solve and take a common-sense approach to situations. He has a close affiliation with clients – a people’s person.
Anna oversees our Pharmacovigilance, Regulatory and Project Management teams, balancing keeping our clients super happy whilst developing and nurturing our growing team.
She has worked in the pharmaceutical industry since 2005 in the business development and operational areas.
Anna acquired her customer centric approach from the hospitality sector where she received extensive training and experience after graduating from university in the US.
She is a strong believer in leading by example and would not expect anyone to do something she was not prepared to do herself.
Vic is Chief Commercial Officer (CCO) and Board member at Arriello. Based in Dublin, Ireland. Vic is responsible for the commercial team comprising, Sales and Marketing, Vendor Management and Corporate Development. Working closely with Arriello’s operational and support teams, Vic leads the development and delivery of company commercial strategy and growth.
Vic has over ten years’ experience in the life science services sector in business development, project management and corporate roles in large global healthcare solution providers. Prior to joining Arriello he was a Director of Global Development in Quality and Compliance.
He holds two degrees, one in Marketing and a Master’s in Management Consultancy from UCD Michael Smurfit School of Business.
Technical Leaders.
Sandra brings over 24 years of experience in the pharmaceutical and management consultancy sectors, with deep expertise in regulatory strategy and global market access. Throughout her career, she has led complex regulatory initiatives across Europe and internationally, working closely with National Competent Authorities and regulatory bodies in both established and emerging markets.
She has successfully overseen the submission of more than 950 Marketing Authorizations in the EU, leveraging both National and European procedures, and has been directly involved in the development of Modules 1 to 5. Sandra is recognized for her strategic approach to dossier preparation, regulatory compliance, and her precision in navigating approval processes worldwide.
In addition to initial submissions, Sandra has substantial experience in post-marketing regulatory activities, having led and supported over 2,000 global regulatory procedures, including renewals, variations, and other lifecycle management processes. Her ability to maintain compliance and product availability across multiple markets demonstrates her comprehensive understanding of regulatory maintenance. She is also adept at handling responses to deficiency letters and addressing regulatory challenges efficiently, always with a focus on maintaining momentum and minimizing time to market.
Sandra is an active member of the regulatory affairs community and holds the MTOPRA designation. For the past three years, she has served as a Working Party member for the TOPRA Symposium, contributing to the planning and delivery of key regulatory discussions. She is passionate about fostering collaboration between industry and regulators, mentoring emerging regulatory professionals, and championing excellence in regulatory science.
As a TOPRA Awards judge, Sandra brings a deep understanding of regulatory complexity, a commitment to quality, and a strong appreciation for innovation and impact in the field.
Rebecca, based in the UK, brings over a decade of experience in Global Regulatory Affairs to the team. Rebecca has an impressive track record in guiding a wide range of therapies and product types through a variety of regulatory pathways. Specifically related to drug development, her expertise includes Phase I-IV Clinical Trials, INDs/NDAs, non-interventional / observational studies, and Expanded Access Programs (EAPs).
In addition, she has also been involved in countless early access mechanisms across the globe, including, PIM, ODD and EAMS. Alongside this experience, Rebecca also has experience in Medical Device development, supporting with MDR, IVDR and sAMD requirements across many regions, ranging from products obtaining CE marking, to preparing medical dossiers for combination therapies.
Having worked extensively on novel drugs, medical devices, and combination therapies, she offers clients a deep understanding of regulatory strategies and pathways, experience that has been obtained through Rebecca’s unique background as both a clinical trial scientist and within the UK Health Authorities, this experience enables her to bridge perspectives, enhancing success and efficiency for our clients.
Throughout her career, Rebecca has been actively involved in developing regulatory strategies to suit client needs and providing a wealth of knowledge to those around her.
Gerlinde is a senior Regulatory Affairs and Pharmacovigilance professional with more than 35 years of experience supporting pharmaceutical and biotechnology companies across Europe and globally.
She has extensive expertise in regulatory strategy, lifecycle management, Marketing Authorization Holder (MAH) responsibilities, product information and labelling, pharmacovigilance, and compliance.
Before joining Arriello, Gerlinde held senior leadership positions at Genericon Pharma, MSD (Merck Sharp & Dohme), and Sanofi-Aventis, leading Regulatory Affairs and Pharmacovigilance functions across diverse product portfolios and international markets. She has extensive experience managing regulatory submissions, marketing authorization transfers, dossier maintenance, lifecycle activities, and complex cross-functional projects.
Her experience spans prescription and OTC medicines, biologics, vaccines, orphan drugs, plasma-derived products, and advanced therapies across a wide range of therapeutic areas. At Arriello, Gerlinde provides strategic and operational regulatory support, helping clients navigate regulatory complexity, maintain compliance, and deliver successful product lifecycle management.
Olga is an experienced pharmaceutical professional with 12 years in the industry, specializing in GxP compliance, quality oversight, and global auditing.
She has proven expertise as a Lead GxP Auditor with extensive experience in conducting complex audits across CROs, vendors, and Marketing Authorization Holders (MAHs) and strong background in regulatory expectations, vendor qualification, pharmacovigilance processes, and quality systems management.
Olga is skilled in applying a risk‑based approach, driving continuous improvement, and fostering effective collaboration across cross‑functional teams, and an active member of ISOP, RQA, and PIPA, demonstrating ongoing commitment to professional development and industry best practices.
Basharat is a global leader with over 19 years of experience in pharmacovigilance, regulatory operations, and business transformation. He has a proven track record of driving operational excellence across complex, multinational life-sciences environments.
As Senior Director of Business Excellence, Basharat leads strategic initiatives to strengthen process efficiency and performance visibility. He partners with delivery and commercial teams to establish KPI governance and a culture of continuous improvement that supports scalability.
His focus includes building governance frameworks that enhance quality and transparency, ensuring data-driven accountability across the business.
Previously, he led large teams and transformation programs at global life-sciences organizations, delivering measurable improvements in productivity and customer satisfaction. Basharat brings deep domain expertise and a passion for operational maturity and innovation.
Alexandra is a multilingual Senior Global Drug Safety and Operations Manager, BSc, MSc, Pharma Mini-MBA, Oxford Women’s Leadership Programme, and PMP®-certified, with 13+ years of experience across clinical trial and post-marketing pharmacovigilance. She brings extensive expertise in global safety operations, pharmacovigilance strategy, and project leadership, supporting pharmaceutical and biotech organizations in delivering compliant and scalable safety systems across EU, UK, US, and global markets.
Throughout her career, Alexandra has partnered with global clients to design, implement, and optimize pharmacovigilance operations across both clinical development and post-marketing environments. She has led complex international projects, built pharmacovigilance processes and teams from the ground up, and overseen safety operations to ensure regulatory compliance and operational efficiency across diverse product portfolios.
Recognized for her strategic thinking and operational leadership, Alexandra is a subject matter expert in clinical safety strategy, process implementation, and pharmacovigilance oversight. She is passionate about strengthening PV systems, driving operational excellence, and delivering inspection-ready safety frameworks that enable organizations to manage risk effectively while maintaining the highest standards of patient safety.
A pharmacist by education, Cláudia has been working in pharmacovigilance since 2015 and as a QPPV/Deputy for multiple companies for over seven years.
Cláudia has experience across a wide range of activities, including ICSR management, medical writing (PSURs, RMPs, and PSMFs), safety communications, signal management, and quality-related aspects, such as audits, inspections, and SOPs elaboration.
She is also a trained auditor with ISO 9001:2015, is fully XEVMPD trained and has knowledge around Medical Device Regulation.
Key Contacts.
Amy is committed to fostering a culture of engagement and driving the growth and development of our people. With over nine years of HR experience, primarily within SMEs in the tech sector, she brings strong expertise in people strategy, employee relations, performance management, and change initiatives. Prior to becoming HR Director, Amy held senior HR leadership roles, where she partnered with executive leadership and drove operational and strategic projects across all areas of the employee experience and lifecycle. She has led HR teams, coached managers, and championed employee wellbeing through innovative programs and resources.
Before her HR career, Amy worked across diverse industries including advertising, PR, music, and hospitality. These experiences sparked her passion for working with people and striving to create employee-centric cultures. Today, that passion drives her approach to building an environment where individuals can thrive, collaborate, and reach their full potential.
Chris is a marketing leader with a career spanning over 25 years. He has worked in a number of roles covering strategic marketing, market insight, product and brand management and ABM. Sector experience includes electrical consumer goods, beverage ingredients and flavours (biotech), food safety & quality, and multiple life science sectors including supplements, medtech and pharma.
An active ‘Fellow’ member of the Chartered Institute of Marketing (CIM), Chris holds a degree in Advertising & Marketing and numerous post graduate qualifications, with 2 master level qualifications from both the CIM and IDM.
Contact Chris for all things marketing and client experience (Cx) related.
Craig has 25+ years finance experience and 15+ years in leadership positions. From working in accounting practices early in his career, to holding various roles across a range of industries & company sizes.
Craig is a fellowship member of the Association of Chartered Certified Accountants (ACCA) and is Six Sigma certified, supporting his passion for continuous improvement.
